Topic
5 articles covering Leukaemia in medical tourism and healthcare in India.
Subscribe via RSS
India now performs 2,000+ BMTs annually. Affordable haematological transplants for global patients — the complete 2026 guide to bone marrow transplant process, costs, and outcomes.
CAR-T cell therapy is now available in India, transforming lymphoma treatment outcomes. Complete guide for African patients with blood cancers — lymphoma, leukemia, and myeloma.
India's homegrown CAR-T therapy NexCAR19 costs $30,000 versus $400,000+ in the USA. Learn about eligibility, the treatment process, and centres offering CAR-T for leukaemia and lymphoma in India.
A comprehensive guide to blood cancer treatment in India for international patients — leukaemia, lymphoma, and myeloma treatment options, costs, hospitals, and outcomes at JCI-accredited haematology centres.
Childhood leukaemia treatment in India for African families — expert paediatric oncology, ALL and AML protocols, bone marrow transplant, and 60–70% cost savings versus Western hospitals.
